Amarendra Neppalli to Humans
This is a "connection" page, showing publications Amarendra Neppalli has written about Humans.
Connection Strength
0.026
-
Comparison of Cilta-cel, an Anti-BCMA CAR-T Cell Therapy, Versus Conventional Treatment in Patients With Relapsed/Refractory Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2022 05; 22(5):326-335.
Score: 0.007
-
Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH. Am J Hematol. 2021 01; 96(1):E5-E8.
Score: 0.007
-
Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy. Leukemia. 2019 09; 33(9):2266-2275.
Score: 0.006
-
IgM Myeloma with Plasma Cell Leukemia: Case Report and Literature Review. Ann Clin Lab Sci. 2017 Sep; 47(5):611-619.
Score: 0.006